These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30821509)

  • 1. Validation of urinary sphingolipid metabolites as biomarker of effect for fumonisins exposure in Kenyan children.
    Wangia RN; Githanga DP; Xue KS; Tang L; Anzala OA; Wang JS
    Biomarkers; 2019 Jun; 24(4):379-388. PubMed ID: 30821509
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of sphinganine, sphingosine and Sa/So ratio in urine of humans exposed to dietary fumonisin B1.
    Qiu M; Liu X
    Food Addit Contam; 2001 Mar; 18(3):263-9. PubMed ID: 11304035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sphinganine and the sphinganine to sphingosine ratio as a biomarker of dietary fumonisins during chronic exposure in ducks.
    Tran ST; Tardieu D; Auvergne A; Bailly JD; Babilé R; Durand S; Benard G; Guerre P
    Chem Biol Interact; 2006 Mar; 160(1):41-50. PubMed ID: 16413517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks.
    Tardieu D; Tran ST; Auvergne A; Babilé R; Benard G; Bailly JD; Guerre P
    Chem Biol Interact; 2006 Mar; 160(1):51-60. PubMed ID: 16412405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of orally administered fumonisin B₁ (FB₁), partially hydrolysed FB₁, hydrolysed FB₁ and N-(1-deoxy-D-fructos-1-yl) FB₁ on the sphingolipid metabolism in rats.
    Hahn I; Nagl V; Schwartz-Zimmermann HE; Varga E; Schwarz C; Slavik V; Reisinger N; Malachová A; Cirlini M; Generotti S; Dall'Asta C; Krska R; Moll WD; Berthiller F
    Food Chem Toxicol; 2015 Feb; 76():11-8. PubMed ID: 25475052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1.
    Soriano JM; González L; Catalá AI
    Prog Lipid Res; 2005 Nov; 44(6):345-56. PubMed ID: 16266752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of sphingolipid metabolism in non-human primates consuming diets of fumonisin-containing Fusarium moniliforme culture material.
    Shephard GS; van der Westhuizen L; Thiel PG; Gelderblom WC; Marasas WF; van Schalkwyk DJ
    Toxicon; 1996 May; 34(5):527-34. PubMed ID: 8783447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice.
    Kim DH; Yoo HS; Lee YM; Kie JH; Jang S; Oh S
    J Toxicol Environ Health A; 2006 Dec; 69(23):2071-82. PubMed ID: 17060094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks.
    Turner PC; Nikiema P; Wild CP
    Mutat Res; 1999 Jul; 443(1-2):81-93. PubMed ID: 10415433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphinganine/sphingosine ratio in plasma and urine as a possible biomarker for fumonisin exposure in humans in rural areas of Africa.
    van der Westhuizen L; Brown NL; Marasas WF; Swanevelder S; Shephard GS
    Food Chem Toxicol; 1999 Dec; 37(12):1153-8. PubMed ID: 10654591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of sphingolipid biosynthesis in rat primary hepatocyte cultures by fumonisin B1 and other structurally related compounds.
    van der Westhuizen L; Shephard GS; Snyman SD; Abel S; Swanevelder S; Gelderblom WC
    Food Chem Toxicol; 1998 Jun; 36(6):497-503. PubMed ID: 9674957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in china.
    Abnet CC; Borkowf CB; Qiao YL; Albert PS; Wang E; Merrill AH; Mark SD; Dong ZW; Taylor PR; Dawsey SM
    Cancer Causes Control; 2001 Nov; 12(9):821-8. PubMed ID: 11714110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
    Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
    Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of urinary sphingolipids in human populations with high and low maize consumption as a possible biomarker of fumonisin dietary exposure.
    Solfrizzo M; Chulze SN; Mallmann C; Visconti A; De Girolamo A; Rojo F; Torres A
    Food Addit Contam; 2004 Nov; 21(11):1090-5. PubMed ID: 15764338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats.
    Voss KA; Plattner RD; Riley RT; Meredith FI; Norred WP
    Mycopathologia; 1998; 141(1):45-58. PubMed ID: 9725030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The induction and persistence of altered sphingolipid biosynthesis in rats treated with fumonisin B1.
    Garren L; Galendo D; Wild CP; Castegnaro M
    Food Addit Contam; 2001 Sep; 18(9):850-6. PubMed ID: 11552753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of fumonisin biomarkers in a cross-sectional study with two high-risk populations in China.
    Xu L; Cai Q; Tang L; Wang S; Hu X; Su J; Sun G; Wang JS
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2010 Aug; 27(8):1161-9. PubMed ID: 20589550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
    Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
    J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of growing swine to dietary exposure to pure fumonisin B1 during an eight-week period: growth and clinical parameters.
    Rotter BA; Thompson BK; Prelusky DB; Trenholm HL; Stewart B; Miller JD; Savard ME
    Nat Toxins; 1996; 4(1):42-50. PubMed ID: 8680753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases.
    Schmelz EM; Dombrink-Kurtzman MA; Roberts PC; Kozutsumi Y; Kawasaki T; Merrill AH
    Toxicol Appl Pharmacol; 1998 Feb; 148(2):252-60. PubMed ID: 9473533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.